KPTI · Karyopharm Therapeutics Inc. · Analyst Estimates
$0.48
-0.04 (-6.84%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current business plan and current capital resources, combined with the uncertainty regarding the availability of additional funding or other strategic alternatives and considering our debt service obligations and financial covenant to maintain minimum liquidity, we have concluded that there is substantial doubt regarding our ability to continue as a going concern within one year after the date the accompanying condensed consolidated financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$11.74M
Shares
22.68M
Volume · Oct 26
1.37M
Avg daily vol (3M)
1.94M
Analyst Estimates
Compare analyst forecasts for Karyopharm Therapeutics Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 23:15 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-6.01
|
-5.85
|
-5.68
|
2
|
-4.76
|
-4.95
|
-4.95
|
-4.95
|
1
|
1
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
130.93M
|
135.63M
|
137.72M
|
5
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-3.72
|
-2.82
|
-1.92
|
2
|
-3.21
|
-4.89
|
-4.89
|
-4.89
|
1
|
0
|
1
|
2
|
|
Revenue
USD
Publication date not stated |
155.79M
|
173.57M
|
198.43M
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.37
|
-1.32
|
-1.26
|
2
|
-1.46
|
-1.21
|
-1.21
|
-1.21
|
0
|
1
|
2
|
1
|
|
Revenue
USD
Publication date not stated |
31.96M
|
33.54M
|
34.60M
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.30
|
-1.21
|
-1.12
|
2
|
-1.09
|
-1.23
|
-1.23
|
-1.23
|
1
|
1
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
33.15M
|
34.31M
|
35.27M
|
5
|
— | — | — | — | — | — | — | — |
Key facts
CIK
1503802
CUSIP
48576U205
13F (30d)
10 filings
10 filers
Visit website
Investor relations